STOCK TITAN

Ultralife Corporation Adds Janie Goddard to its Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary

Ultralife Corporation (NASDAQ: ULBI) has appointed Janie Goddard as its new Director. Chairman Bradford Whitmore expressed enthusiasm for her extensive leadership experience, particularly in global medical devices and industrial markets, which is expected to enhance Ultralife’s strategic growth. Goddard's prior roles include Divisional Chief Executive at Halma plc and Divisional President at Novanta, alongside leadership positions at Welch Allyn, Covidien, and Johnson & Johnson. With a B.S. from Washington University and an M.B.A. from Harvard, her expertise is poised to support Ultralife's business objectives.

Positive
  • Appointment of Janie Goddard as Director brings extensive leadership experience.
  • Goddard's background in medical devices may enhance Ultralife’s growth strategy.
Negative
  • None.

NEWARK, N.Y., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) announced today the addition of Janie Goddard as Director of the Company.

Chairman Bradford Whitmore said, “We are pleased to welcome Janie to our Board of Directors and look forward to leveraging her extensive business career. Janie is an experienced, results-driven executive who brings a strong track record of P&L leadership within global companies and a background in commercial execution, strategic marketing, and product development. Her depth and breadth of experience in global medical device and industrial markets will add significant perspective in the support of Ultralife’s growth strategy.”

Most recently, Ms. Goddard has served as a Divisional Chief Executive for the Environmental & Analysis Sector at Halma plc. Before joining Halma, Ms. Goddard served as Divisional President of the Detection & Analysis Business Unit at Novanta, where she led a portfolio of solutions for medical device OEMs. Prior to Novanta, Ms. Goddard served in leadership roles at Welch Allyn (acquired by Hill-Rom), Covidien (acquired by Medtronic), and Johnson & Johnson. Ms. Goddard also serves on the board of directors of Methode Electronics, Inc., a public company (NYSE: MEI) that develops and manufactures custom solutions for the transportation (including electric vehicles), industrial and medical markets. She received a B.S. in Business Administration from Washington University in St. Louis and an M.B.A. from Harvard Business School.

About Ultralife Corporation

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorporation.com.

Company Contact: Investor Relations Contact:
Ultralife Corporation LHA
Philip A. Fain Jody Burfening
(315) 210-6110  (212) 838-3777
pfain@ulbi.com jburfening@lhai.com

FAQ

What is the significance of Janie Goddard's appointment at Ultralife Corporation?

Janie Goddard's appointment as Director is significant due to her extensive experience in global medical devices and strategic leadership, which can enhance Ultralife's growth strategy.

What companies did Janie Goddard work for before joining Ultralife Corporation?

Before joining Ultralife, Janie Goddard held leadership roles at Halma plc, Novanta, Welch Allyn, Covidien, and Johnson & Johnson.

What expertise does Janie Goddard bring to Ultralife Corporation?

Goddard brings expertise in commercial execution, strategic marketing, and product development within the global medical device and industrial markets.

How might Janie Goddard's leadership impact Ultralife Corporation's growth?

Her leadership is expected to provide new perspectives and strategies that could strengthen Ultralife’s market position and drive growth.

Ultralife Corporation

NASDAQ:ULBI

ULBI Rankings

ULBI Latest News

ULBI Stock Data

121.04M
16.12M
3.08%
74.15%
1.01%
Electrical Equipment & Parts
Miscellaneous Electrical Machinery, Equipment & Supplies
Link
United States of America
NEWARK